Stock code

SSE: 603127
HKEX: 06127
JOINN Makes a Splendid Appearance at the 4th World ADC Asia Summit, Discussing the Future of Antibody-Drug Conjugates Together

2025-04-17

The 4th World ADC Asia will take place in Incheon, South Korea, from June 10 to 12, 2025. As the annual event for Antibody-Drug Conjugate (ADC) technology, this conference will focus on the diversified development of Payload-linker technology platforms and innovative applications of dual-target ADCs. Leading experts, scholars, and industry elites from around the world will gather to discuss the latest advancements and future trends in ADC technology. The conference also provides an international exchange platform to promote collaboration between academia and industry.

Dr. Yongbin Zhang, vice president and chief technology officer of JOINN, will attend the conference and share posters. At that time, we also set up a booth (Booth #23) to introduce in detail the company's solutions in the whole life cycle of drugs. Colleagues in the industry are welcome to come and discuss.

Joining the 4th World ADC Asia, JOINN will showcase its latest research achievements in the ADC field. As a company dedicated to biopharmaceutical R&D services, JOINN has established significant competitive advantages in the ADC sector through its strong R&D capabilities and extensive project experience. Its integrated service platform covers the entire process from early development to commercial production, offering high-quality and efficient R&D support to clients. JOINN's experienced team of experts, equipped with over a decade of research experience, has successfully guided multiple ADC drugs through regulatory approvals in both China and other countries. By participating in this summit, JOINN aims to further showcase its capabilities, strengthen partnerships, and contribute to advancing the ADC field globally.


Welcome to click on "Schedule a Meeting" below to set the meeting time. We look forward to meeting you!



Back to list <